Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra K Gardino

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Enzymology|July 5, 2007
Functional dynamics of response regulators using NMR relaxation techniquesAlexandra K Gardino, Dorothee Kern
Seminars in Cell & Developmental Biology|September 28, 2011
14-3-3 proteins as signaling integration points for cell cycle control and apoptosisAlexandra K Gardino, Michael B Yaffe
Seminars in Cancer Biology|May 9, 2006
Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoformsAlexandra K Gardino, Stephen J Smerdon, Michael B Yaffe
Journal of Molecular Biology|July 24, 2003
The NMR solution structure of BeF(3)(-)-activated Spo0F reveals the conformational switch in a phosphorelay systemAlexandra K Gardino, Brian F Volkman, Ho S Cho, et al.
Molecular & Cellular Oncology|September 26, 2018
Targeting kinases with precisionAlexandra K Gardino, Erica K Evans, Joseph L Kim, et al.
Cell|May 15, 2012
Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networksMichael J Lee, Albert S Ye, Alexandra K Gardino, et al.
Cell|December 17, 2009
Transient non-native hydrogen bonds promote activation of a signaling proteinAlexandra K Gardino, Janice Villali, Aleksandr Kivenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2018
Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal TumorsYemarshet K Gebreyohannes, Agnieszka Wozniak, Madalina-Elena Zhai, et al.
Leukemia|March 27, 2019
Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosisJohannes Lübke, Nicole Naumann, Sebastian Kluger, et al.
Plos Biology|February 4, 2010
A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpointMarcel A T M van Vugt, Alexandra K Gardino, Rune Linding, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Enzymology|July 5, 2007
Functional dynamics of response regulators using NMR relaxation techniquesAlexandra K Gardino, Dorothee Kern
Seminars in Cell & Developmental Biology|September 28, 2011
14-3-3 proteins as signaling integration points for cell cycle control and apoptosisAlexandra K Gardino, Michael B Yaffe
Seminars in Cancer Biology|May 9, 2006
Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoformsAlexandra K Gardino, Stephen J Smerdon, Michael B Yaffe
Journal of Molecular Biology|July 24, 2003
The NMR solution structure of BeF(3)(-)-activated Spo0F reveals the conformational switch in a phosphorelay systemAlexandra K Gardino, Brian F Volkman, Ho S Cho, et al.
Molecular & Cellular Oncology|September 26, 2018
Targeting kinases with precisionAlexandra K Gardino, Erica K Evans, Joseph L Kim, et al.
Cell|May 15, 2012
Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networksMichael J Lee, Albert S Ye, Alexandra K Gardino, et al.
Cell|December 17, 2009
Transient non-native hydrogen bonds promote activation of a signaling proteinAlexandra K Gardino, Janice Villali, Aleksandr Kivenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2018
Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal TumorsYemarshet K Gebreyohannes, Agnieszka Wozniak, Madalina-Elena Zhai, et al.
Leukemia|March 27, 2019
Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosisJohannes Lübke, Nicole Naumann, Sebastian Kluger, et al.
Plos Biology|February 4, 2010
A mitotic phosphorylation feedback network connects Cdk1, Plk1, 53BP1, and Chk2 to inactivate the G(2)/M DNA damage checkpointMarcel A T M van Vugt, Alexandra K Gardino, Rune Linding, et al.
Pageof 2